Study with Us
graduate study at the department of oncology
We warmly invite you to join us for a unique opportunity to study with leading scientists in the field of oncology and radiation biology.
The Department offers an established, world-leading, graduate training programme. Our degree courses are a critical element in our drive to revolutionise training in radiation oncology and cancer research in the UK. We are striving to make advances in radiation biology and to translate these into improved clinical outcomes for cancer patients.
Please take a moment to review the different courses available in this department and to hear what our students really think on our Student Experience page.
- DPhil in Oncology
- MRes in Oncology
- MSc in Radiation Biology
- MSc in Precision Cancer Medicine (Part-time and online)
- MSc Experimental and Translational Therapeutics (Part-time, delivered in collaboration with the Department for Continuing Education)
Contact us at the Graduate Studies Office if you have more questions that are not answered here.
Professor Tim Maughan outlines the flagship work of the FOCUS4 trials, whose results were presented this weekend at the European Society of Medical Oncology (ESMO) annual meeting
Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS
15 September 2021
A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.
University of Oxford Announces Opening of PanDox Phase 1 Study investigating Targeted Drug Delivery by Focused Ultrasound for Pancreatic Cancer
1 July 2021
The University of Oxford is pleased to announce commencement of enrollment for the Phase I PanDox study of thermosensitive liposomal doxorubicin triggered by focused ultrasound in patients with pancreatic cancer.
24 June 2021
Dr Lee (Department of Oncology) received the award to acknowledge his contributions during the COVID-19 pandemic, through the establishment of the UK Coronavirus Cancer Monitoring Project.